TPST Stock Analysis: Buy, Sell, or Hold?
TPST - Tempest Therapeutics, Inc. Common Stock
$1.23
-0.02 (-1.60%)
▼
5d:
-1.6%
30d:
-30.9%
90d:
-43.06%
BUY
HIGH Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When TPST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TPST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: TPST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: TPST is currently trading at $1.23, which is considered oversold relative to its 30-day fair value range of $1.25 to $1.82.
Technical Outlook: Technically, TPST is in a strong downtrend. The price is currently testing key support at $1.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TPST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+794.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TPST is in a strong downtrend. The price is currently testing key support at $1.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TPST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+794.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.25 -
$1.82
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 794.3% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$1.25 -
$1.82
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.23
Resistance Level
$1.86
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.02
Wall Street Target
$11.00
(+794.3%)
Share & Embed Analysis
Last updated: June 20, 2026 11:45 PM ET
Data refreshes hourly during market hours. Next update: 12:45 AM
Data refreshes hourly during market hours. Next update: 12:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TPST showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Matthew Angel
BUY
231482 shares
2026-03-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 51 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 53 HOLD |
|
CNTA
Centessa Pharmaceuticals… |
STRONG BUY
11 analysts |
$44 | 60 HOLD |
